Updating results

2 results

Sort: Relevance | Date

Nintedanib for treating progressive fibrosing interstitial lung disease [ID1599]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 21 October 2019.

Technology appraisal guidance In consultation

Atezolizumab with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer [ID1522]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 24 October 2019.

Technology appraisal guidance In consultation